FDA Classifies Spinal Imaging System for Neuraxial Procedures into Class II

The U.S. Food and Drug Administration (FDA) has classified the spinal imaging system for neuraxial procedures into Class II with special controls. This regulatory action is intended to ensure the safety and effectiveness of the device and enhance patient access to beneficial innovative devices by reducing regulatory burdens.